Antimicrobial development and the risk-benefit assessment: recent adverse events and their implications.
Tillotson
Glenn S
GS
Blondeau
Joseph M
JM
D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000737:chemistry; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors; D013678:Technology, Pharmaceutical / Q000639:trends*
D000890:Anti-Infective Agents